Silverback Therapeutics is a Seattle-based biopharmaceutical company developing ImmunoTAC therapies targeting previously inaccessible disease pathways.
9
Funding Rounds
$444.7m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Pe*** Th****** | - | - |
Name | Phone | Social networks | |
---|---|---|---|
Pe*** Th****** | - | - | |
Jo* Ro** | - | - | |
Sa*** Is**** J.** | - | - | - |
Vi**** L. Ca*** | - | - | - |
Ro**** M. He******* | - | - | - |
La*** Sh***** | - | - | - |
The company Silverback Therapeutics has raised a total of $116m in funding over 9 rounds.